加拿大分离的百日咳博德特氏菌菌株菌毛fim3基因的多态性
Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada.
作者信息
Tsang Raymond S W, Lau Allan K H, Sill Michelle L, Halperin Scott A, Van Caeseele Paul, Jamieson Frances, Martin Irene E
机构信息
National Microbiology Laboratory, Health Canada, Winnipeg, Manitoba, Canada R3E 3R2.
出版信息
J Clin Microbiol. 2004 Nov;42(11):5364-7. doi: 10.1128/JCM.42.11.5364-5367.2004.
Abstract
The fim genes which code for the fimbria protective antigens present in both the inactivated whole-cell and acellular vaccines were analyzed in 86 Canadian Bordetella pertussis isolates. At least one of the novel mutations identified was found to involve a surface epitope that has been mapped by serum antibodies from infected or vaccinated subjects.
摘要
对86株加拿大百日咳博德特氏菌分离株中编码存在于灭活全细胞疫苗和无细胞疫苗中的菌毛保护性抗原的fim基因进行了分析。发现所鉴定的至少一种新突变涉及一个已由感染或接种疫苗受试者的血清抗体定位的表面表位。
相似文献
1
Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada.
J Clin Microbiol. 2004 Nov;42(11):5364-7. doi: 10.1128/JCM.42.11.5364-5367.2004.
2
Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
Vaccine. 2018 Mar 7;36(11):1345-1352. doi: 10.1016/j.vaccine.2018.02.017. Epub 2018 Feb 9.
3
Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine.
Can J Microbiol. 2005 Oct;51(10):887-92. doi: 10.1139/w05-079.
4
Small mutations in Bordetella pertussis are associated with selective sweeps.
PLoS One. 2012;7(9):e46407. doi: 10.1371/journal.pone.0046407. Epub 2012 Sep 28.
5
Bordetella pertussis isolates in Finland after acellular vaccination: serotype change and biofilm formation.
Clin Microbiol Infect. 2024 May;30(5):683.e1-683.e3. doi: 10.1016/j.cmi.2024.01.021. Epub 2024 Feb 2.
6
Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro.
Vaccine. 2019 Jan 3;37(1):80-89. doi: 10.1016/j.vaccine.2018.11.028. Epub 2018 Nov 23.
7
Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
BMC Microbiol. 2008 Sep 25;8:162. doi: 10.1186/1471-2180-8-162.
8
Population diversity among Bordetella pertussis isolates, United States, 1935-2009.
Emerg Infect Dis. 2012 Aug;18(8):1248-55. doi: 10.3201/eid1808.120082.
9
[Modern strains of Bordetella pertussis: immunobiological properties and vaccine improvement].
Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug(4):20-5.
10
Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007.
Clin Vaccine Immunol. 2014 Feb;21(2):165-73. doi: 10.1128/CVI.00641-13. Epub 2013 Dec 4.
引用本文的文献
1
Population dynamics and antigenic drift of following whole cell vaccine replacement, Barcelona, Spain, 1986-2015.
Emerg Microbes Infect. 2019;8(1):1711-1720. doi: 10.1080/22221751.2019.1694395.
2
Short-Read Whole-Genome Sequencing for Laboratory-Based Surveillance of Bordetella pertussis.
J Clin Microbiol. 2017 May;55(5):1446-1453. doi: 10.1128/JCM.02436-16. Epub 2017 Feb 22.
3
Variation in Bordetella pertussis Susceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014).
PLoS One. 2015 Sep 25;10(9):e0138941. doi: 10.1371/journal.pone.0138941. eCollection 2015.
4
Roads to the development of improved pertussis vaccines paved by immunology.
Pathog Dis. 2015 Nov;73(8):ftv067. doi: 10.1093/femspd/ftv067. Epub 2015 Sep 6.
5
Virulence Factors Variation Among Bordetella Pertussis Isolates in Iran.
Int J Mol Cell Med. 2015 Spring;4(2):138-42.
6
Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007.
Clin Vaccine Immunol. 2014 Feb;21(2):165-73. doi: 10.1128/CVI.00641-13. Epub 2013 Dec 4.
7
Multilocus Sequence Analysis of Housekeeping Genes and Antigenic Determinant Genes in Bordetella pertussis Strains Isolated in Korea.
Osong Public Health Res Perspect. 2011 Sep;2(2):115-26. doi: 10.1016/j.phrp.2011.08.003. Epub 2011 Aug 4.
8
Genetic analysis of Bordetella pertussis isolates from the 2008-2010 pertussis epidemic in Japan.
PLoS One. 2013 Oct 4;8(10):e77165. doi: 10.1371/journal.pone.0077165. eCollection 2013.
9
Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009.
J Clin Microbiol. 2013 Feb;51(2):422-8. doi: 10.1128/JCM.02036-12. Epub 2012 Nov 21.
10
Small mutations in Bordetella pertussis are associated with selective sweeps.
PLoS One. 2012;7(9):e46407. doi: 10.1371/journal.pone.0046407. Epub 2012 Sep 28.
本文引用的文献
1
Whooping cough--a continuing problem.
BMJ. 2002 Jun 29;324(7353):1537-8. doi: 10.1136/bmj.324.7353.1537.
2
Multilocus sequence typing of Bordetella pertussis based on surface protein genes.
J Clin Microbiol. 2002 Jun;40(6):1994-2001. doi: 10.1128/JCM.40.6.1994-2001.2002.
3
Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity.
Vaccine. 2002 Jan 31;20(9-10):1290-4. doi: 10.1016/s0264-410x(01)00479-0.
4
Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.
J Clin Microbiol. 2001 Dec;39(12):4396-403. doi: 10.1128/JCM.39.12.4396-4403.2001.
5
Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland.
Vaccine. 2001 Nov 12;20(3-4):299-303. doi: 10.1016/s0264-410x(01)00356-5.
6
Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.
Infect Immun. 2001 Sep;69(9):5520-8. doi: 10.1128/IAI.69.9.5520-5528.2001.
7
Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines.
Vaccine. 2001 Apr 30;19(23-24):3248-52. doi: 10.1016/s0264-410x(01)00013-5.
8
Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999.
J Infect Dis. 2000 Nov;182(5):1402-8. doi: 10.1086/315881. Epub 2000 Oct 9.
9
Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization.
Infect Immun. 2000 Jun;68(6):3763-7. doi: 10.1128/IAI.68.6.3763-3767.2000.
10
Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine.
Vaccine. 1999 Jun 4;17(20-21):2651-60. doi: 10.1016/s0264-410x(99)00038-9.
Zotero 插件